Search

Your search keyword '"Santacruz E"' showing total 320 results

Search Constraints

Start Over You searched for: Author "Santacruz E" Remove constraint Author: "Santacruz E"
320 results on '"Santacruz E"'

Search Results

251. CoMFA study of distamycin analogs binding to the minor-groove of DNA: a unified model for broad-spectrum activity.

252. 3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment.

253. Enantioselective benzoylation of alpha-amino esters using (S)-1-benzoyl-2- (alpha-acetoxyethyl)benzimidazole, a chiral benzimidazolide.

254. Design of inhibitors of the MurF enzyme of Streptococcus pneumoniae using docking, 3D-QSAR, and de Novo design.

256. Mechanism of spasmolytic activity of a fraction of Sarcostemma brevistigma Wight.

257. Understanding interactions of gastric inhibitory polypeptide (GIP) with its G-protein coupled receptor through NMR and molecular modeling.

258. Pharmacophore modeling in drug discovery and development: an overview.

259. The B(OH)-NH Analog Is a Surrogate for the Amide Bond (CO-NH) in Peptides:  An ab Initio Study.

260. A simple sample preparation with HPLC-UV method for estimation of tiropramide from plasma: application to bioequivalence study.

261. Validated HPTLC method of analysis for artemether and its formulations.

263. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil.

264. Stationary Points on the PES of N-Methoxy Peptides and Their Boron Isosteres:  An Ab Initio Study.

265. Decreased B16F10 melanoma growth and impaired tumour vascularization in BDF1 mice with quercetin-cyclodextrin binary system.

266. Synthesis and evaluation of uterine relaxant activity for a novel series of substituted p-hydroxyphenylethanolamines.

267. Design, synthesis and evaluation of naphthalene-2-carboxamides as reversal agents in MDR cancer.

268. Enhancement of dissolution profile by solid dispersion (kneading) technique.

269. Successive explosions in Mumbai the economic center of India.

270. Comparative residue interaction analysis (CoRIA): a 3D-QSAR approach to explore the binding contributions of active site residues with ligands.

271. Docking studies and development of novel 5-heteroarylamino-2,4-diamino-8-chloropyrimido-[4,5-b]quinolines as potential antimalarials.

272. The ω, φ, and ψ Space of N-Hydroxy-N-methylacetamide and N-Acetyl-N '-hydroxy-N '-methylamide of Alanine and Their Boron Isosteres.

273. Enzymatic studies of cisplatin induced oxidative stress in hepatic tissue of rats.

274. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety.

275. Effect of surfactants on the dissociation constants of ascorbic and maleic acids.

276. Design, synthesis and evaluation of racemic 1-(4-hydroxyphenyl)-2-[3-(substituted phenoxy)-2-hydroxy-1-propyl]amino-1-propanol hydrochlorides as novel uterine relaxants.

277. Cyclodextrin complexes of valdecoxib: properties and anti-inflammatory activity in rat.

278. Solution conformation of Substance P antagonists-[D-Arg1, D-Trp7,9, Leu11]-SP, [D-Arg1, D-Pro2, D-Trp7,9, Leu11]-SP and [D-Pro2, D-Trp7,9]-SP by CD, NMR and MD simulations.

279. Design, synthesis and evaluation of 5-substituted amino-2,4-diamino-8-chloropyrimido-[4,5-b]quinolines as novel antimalarials.

280. Chronobiological and chronopharmacological studies of ketoprofen and its solid dispersion form using adjuvant arthritis model in rats.

281. Comparative protein modeling of methionine S-adenosyltransferase (MAT) enzyme from Mycobacterium tuberculosis: a potential target for antituberculosis drug discovery.

282. A CoMFA study of COX-2 inhibitors with receptor based alignment.

283. Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system.

284. Encapsulation of water-insoluble drug by a cross-linking technique: effect of process and formulation variables on encapsulation efficiency, particle size, and in vitro dissolution rate.

285. Coated wire chromium(III) ion-selective electrode based on azamacrocycles.

286. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.

287. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases.

288. A 3D-QSAR of angiotensin II (AT1) receptor antagonists based on receptor surface analysis.

289. Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases.

290. Evaluation of the fluidity and functionality of the renal cortical brush border membrane in experimental diabetes in rats.

291. Preparation and evaluation of a liposomal formulation of sodium cromoglicate.

292. Oxidative stress and gene expression of antioxidant enzymes in the renal cortex of streptozotocin-induced diabetic rats.

293. CoMFA and CoMSIA studies of angiotensin (AT1) receptor antagonists.

294. Amadori product and age formation during nonenzymatic glycosylation of bovine serum albumin in vitro.

295. Voltammetric determination of lead at chemically modified electrodes based on crown ethers.

296. [Impact of prenatal steroids on morbimortality of eutrophic premature newborns].

297. Extract of Juglandaceae regia inhibits growth, in-vitro adherence, acid production and aggregation of Streptococcus mutans.

298. Potential of the aqueous extract of Terminalia chebula as an anticaries agent.

299. Calculation of relative binding free energy difference of DHFR inhibitors by a finite difference thermodynamic integration (FDTI) approach.

300. Responses of intestinal and renal alpha-glycosidases to alloxan and streptozotocin-induced diabetes: a comparative study.

Catalog

Books, media, physical & digital resources